Is There Evidence Supporting the Use of FMT in Cancer?
Preclinical and early-phase clinical trials have provided some encouraging results. For instance, a study published in Science demonstrated that FMT could improve the response to PD-1 blockade in melanoma patients. However, more extensive and rigorous clinical trials are needed to confirm these findings and establish standardized protocols.
